ORP N Stock Overview
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Orpea SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €145.35 |
52 Week High | €544.73 |
52 Week Low | €279.73 |
Beta | 1.12 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -94.42% |
Recent News & Updates
Recent updates
Shareholder Returns
ORP N | MX Healthcare | MX Market | |
---|---|---|---|
7D | 0% | -6.8% | -2.2% |
1Y | n/a | -0.9% | 0.6% |
Return vs Industry: Insufficient data to determine how ORP N performed against the MX Healthcare industry.
Return vs Market: Insufficient data to determine how ORP N performed against the MX Market.
Price Volatility
ORP N volatility | |
---|---|
ORP N Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.5% |
Market Average Movement | 3.8% |
10% most volatile stocks in MX Market | 6.1% |
10% least volatile stocks in MX Market | 1.7% |
Stable Share Price: ORP N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ORP N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 71,000 | Laurent Guillot | www.orpea-corp.com |
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state.
Orpea SA Fundamentals Summary
ORP N fundamental statistics | |
---|---|
Market cap | Mex$3.47b |
Earnings (TTM) | -Mex$6.08b |
Revenue (TTM) | Mex$89.79b |
0.0x
P/S Ratio-0.6x
P/E RatioIs ORP N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ORP N income statement (TTM) | |
---|---|
Revenue | €4.52b |
Cost of Revenue | €3.53b |
Gross Profit | €995.99m |
Other Expenses | €1.30b |
Earnings | -€306.54m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -4.74 |
Gross Margin | 22.02% |
Net Profit Margin | -6.78% |
Debt/Equity Ratio | 256.1% |
How did ORP N perform over the long term?
See historical performance and comparison